Showing results (451-460 of 520) with videos related to

Sort By:
Pageof 52
Molecular & Cellular Proteomics : MCP|March 24, 2019
<i>Salmonella</i> Effectors SseK1 and SseK3 Target Death Domain Proteins in the TNF and TRAIL Signaling PathwaysJoshua P M Newson, Nichollas E Scott, Ivy Yeuk Wah Chung, et al.
Environmental Monitoring and Assessment|May 17, 2008
A bioassessment approach for mid-continent great rivers: the Upper Mississippi, Missouri, and Ohio (USA)T R Angradi, D W Bolgrien, T M Jicha, et al.
The Journal of Clinical Investigation|May 1, 1981
Comparison of radionuclide and contrast ventriculography for detection and quantitation of regions of myocardial ischemia in dogsM W Kronenberg, M L Born, C W Smith, et al.
American Journal of Obstetrics & Gynecology MFM|March 18, 2023
Prenatal syphilis screening among pregnant Medicaid enrollees by sexually transmitted infection history as well as race and ethnicityLindsey R Hammerslag, Rachel E Campbell-Baier, Caitlin A Otter, et al.
Nature Communications|March 11, 2020
Author Correction: Lin28 and let-7 regulate the timing of cessation of murine nephrogenesisAlena V Yermalovich, Jihan K Osborne, Patricia Sousa, et al.
Frontiers in Neuroscience|February 22, 2020
Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate DiagnosisAdam D Kennedy, Kirk L Pappan, Taraka Donti, et al.
Leukemia|February 7, 2015
The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancyL D Wang, T N Rao, R G Rowe, et al.
Frontiers in Neuroscience|May 29, 2019
2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate DiagnosisAdam D Kennedy, Kirk L Pappan, Taraka Donti, et al.
Nature Communications|January 13, 2019
Lin28 and let-7 regulate the timing of cessation of murine nephrogenesisAlena V Yermalovich, Jihan K Osborne, Patricia Sousa, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 27, 2006
Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain statesVictor I Ilyin, James D Pomonis, Garth T Whiteside, et al.
Pageof 52